eli lilly retatrutide clinical trials infiltrates anti-obesity market as Phase III trial for begins ESC 2024: Retatrutide improves lipid

Body composition in anorexia nervosa: Meta-analysis and meta-regression of cross-sectional and longitudinal studies

Retatrutide and tesamorelin The combination of tesamorelin and retatrutide targets both visceral fat reduction and overall weight loss

Medically reviewed 27/04/26 by Roger Compton (GPhC 2082993), M.Pharm

Chen: "Now that weve reviewed the therapy, its administration, and follow-up plan, do you feel ready to explore this option?" Monica: "Yes, lets try it

The included studies varied in design, populations, drug regimens, treatment duration, and body-composition methods

The expectation is that some of these will receive regulatory approval in the next few years